Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it
Maintaining weight loss after medication ends is a difficult transition, prompting researchers to test two practical support options…
Consuming fat before carbohydrates reduces post-meal blood glucose
In treating diabetes, post-meal elevation of glucose levels is an important therapeutic target. Existing clinical studies indicate that…
A New King of The GLP-1s Could Be Crowned – Cardiac Wire
A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
Digital companion apps help secure long-term habits during GLP-1 therapy
Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
Popular diabetes drugs do not alter the risk of developing a blinding eye condition
An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) – a type of…
Physical activity declines after starting GLP-1 obesity treatments
Adults with obesity losing weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which…
SMOC1 gene plays a surprising role in the development of type 2 diabetes
Scientists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in…
Study shows prediabetes remission does not always require weight loss
New evidence shows that restoring normal glucose regulation can shield against diabetes even without weight loss, reshaping prevention…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…